• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

干细胞在心血管移植组织工程中的应用。

Application of stem cells for cardiovascular grafts tissue engineering.

作者信息

Wu Kaihong, Liu Ying Long, Cui Bin, Han Zhongchao

机构信息

Pediatric Cardiac Center, Cardiovascular Institute and Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

出版信息

Transpl Immunol. 2006 Jun;16(1):1-7. doi: 10.1016/j.trim.2006.03.004. Epub 2006 Apr 5.

DOI:10.1016/j.trim.2006.03.004
PMID:16701169
Abstract

Congenital and acquired heart diseases are leading causes of morbidity and mortality world-wide. Currently, the synthetic materials or bioprosthetic replacement devices for cardiovascular surgery are imperfect and subject patients to one or more ongoing risks including thrombosis, limited durability and need for reoperations due to lack of growth in children and young adults. Suitable replacement grafts should have appropriate characteristics, including resistance to infection, low immunogenicity, good biocompatability and thromboresistance, with appropriate mechanical and physiological properties. Tissue engineering is a new scientific field aiming at fabrication of living, autologous grafts having structure or function properties that can be used to restore, maintain or improve tissue function. The use of autologous stem cells in cardiovascular tissue engineering is quite promising due to their capacity of self-renewal, high proliferation, and differentiation into specialized progeny. Progress has been made in engineering the various components of the cardiovascular system, including myocardial constructs, heart valves, and vascular patches or conduits with autologous stem cells. This paper will review the current achievements in stem cell-based cardiovascular grafts tissue engineering, with an emphasis on its clinical or possible clinical use in cardiovascular surgery.

摘要

先天性和后天性心脏病是全球发病和死亡的主要原因。目前,用于心血管手术的合成材料或生物假体置换装置并不完美,会使患者面临一种或多种持续风险,包括血栓形成、耐久性有限以及由于儿童和年轻人缺乏生长而需要再次手术。合适的替代移植物应具有适当的特性,包括抗感染性、低免疫原性、良好的生物相容性和抗血栓性,以及适当的机械和生理特性。组织工程是一个新的科学领域,旨在制造具有可用于恢复、维持或改善组织功能的结构或功能特性的活的自体移植物。由于自体干细胞具有自我更新、高增殖以及分化为特定子代的能力,因此在心血管组织工程中的应用前景广阔。利用自体干细胞对心血管系统的各个组成部分进行工程构建已取得进展,包括心肌构建体、心脏瓣膜以及血管补片或导管。本文将综述基于干细胞的心血管移植物组织工程的当前成果,重点关注其在心血管手术中的临床应用或可能的临床应用。

相似文献

1
Application of stem cells for cardiovascular grafts tissue engineering.干细胞在心血管移植组织工程中的应用。
Transpl Immunol. 2006 Jun;16(1):1-7. doi: 10.1016/j.trim.2006.03.004. Epub 2006 Apr 5.
2
The development of tissue-engineered grafts for reconstructive cardiothoracic surgical applications.用于心胸重建手术的组织工程移植物的研发。
Pediatr Res. 2008 May;63(5):559-68. doi: 10.1203/01.pdr.0000305938.92695.b9.
3
Advancing vascular tissue engineering: the role of stem cell technology.推进血管组织工程:干细胞技术的作用。
Trends Biotechnol. 2005 Sep;23(9):461-7. doi: 10.1016/j.tibtech.2005.06.006.
4
Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells.植入自体骨髓细胞的组织工程化血管自体移植物的中期临床结果。
J Thorac Cardiovasc Surg. 2005 Jun;129(6):1330-8. doi: 10.1016/j.jtcvs.2004.12.047.
5
Tissue engineering therapy for cardiovascular disease.心血管疾病的组织工程治疗
Circ Res. 2003 May 30;92(10):1068-78. doi: 10.1161/01.RES.0000073844.41372.38.
6
Cellular therapy and myocardial tissue engineering: the role of adult stem and progenitor cells.细胞治疗与心肌组织工程:成体干细胞和祖细胞的作用
Eur J Cardiothorac Surg. 2006 Nov;30(5):770-81. doi: 10.1016/j.ejcts.2006.08.003. Epub 2006 Sep 11.
7
Heart valve tissue engineering.心脏瓣膜组织工程
Transpl Immunol. 2004 Apr;12(3-4):359-65. doi: 10.1016/j.trim.2003.12.010.
8
Prenatally harvested cells for cardiovascular tissue engineering: fabrication of autologous implants prior to birth.产前采集细胞用于心血管组织工程:在出生前制备自体移植物。
Placenta. 2011 Oct;32 Suppl 4:S316-9. doi: 10.1016/j.placenta.2011.04.001. Epub 2011 May 14.
9
Stem cells: new cell source for myocardial constructs tissue engineering.干细胞:心肌构建组织工程的新细胞来源。
Med Hypotheses. 2006;67(6):1326-9. doi: 10.1016/j.mehy.2006.04.065. Epub 2006 Jul 11.
10
Tissue engineering of autologous human heart valves using cryopreserved vascular umbilical cord cells.使用冷冻保存的脐血管细胞进行自体人体心脏瓣膜的组织工程。
Ann Thorac Surg. 2006 Jun;81(6):2207-16. doi: 10.1016/j.athoracsur.2005.12.073.

引用本文的文献

1
Embryoid body formation from embryonic and induced pluripotent stem cells: Benefits of bioreactors.从胚胎干细胞和诱导多能干细胞形成类胚体:生物反应器的优势。
World J Stem Cells. 2009 Dec 31;1(1):11-21. doi: 10.4252/wjsc.v1.i1.11.
2
Adipose derived stem cells and smooth muscle cells: implications for regenerative medicine.脂肪来源干细胞与平滑肌细胞:对再生医学的启示
Stem Cell Rev Rep. 2009 Sep;5(3):256-65. doi: 10.1007/s12015-009-9084-y. Epub 2009 Aug 11.